Lung Cancer Trial, Recruiting NCT07328945 Sponsor: Shanghai Pulmonary Hospital, Shanghai, China Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07328945
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old
  • You have been diagnosed with non-small cell lung cancer confirmed by a tissue or cell sample test
  • You have at least one tumour that can be measured on a scan and has not already been treated with radiation, freezing therapy, or similar local treatments (confirm with trial site for exact size requirements)
  • You are relatively well and able to carry out daily activities — scored 0 to 2 on a standard health performance scale (confirm with trial site)
  • Your doctors expect you to live for at least 3 more months
  • Your liver is working well enough, based on recent blood tests showing normal or near-normal liver levels
  • Your kidneys are working well enough, based on a standard calculation of kidney function
  • Your blood clotting levels are within an acceptable range (or within the target range if you are already taking blood thinners)
  • If you are a woman who could become pregnant, you must have a negative pregnancy test within 3 days before starting the trial
  • If there is any chance you or your partner could become pregnant, you must use highly effective contraception during the trial and for at least 180 days after finishing treatment (not being sexually active is also acceptable if that is your usual practice)
  • You are willing to take part, can sign a consent form, and are able to attend follow-up appointments

Who may not be able to join:

  • You are currently taking part in another clinical trial or have taken an experimental drug or used an experimental device in the past 4 weeks
  • You have received certain anti-cancer herbal or immune-boosting medicines in the past 2 weeks, or had major surgery in the past 3 weeks
  • You are currently experiencing active coughing up of blood, a serious bowel blockage, abdominal infection, or cancer that has spread to the lining of the abdomen in a way that needs treatment
  • Cancer has spread to your brain or the lining around your brain and is currently active or untreated
  • You have previously received an organ transplant or bone marrow transplant
  • You have severe heart failure or a serious heart rhythm problem that is not well controlled
  • You have had a heart attack, stroke, unstable chest pain, or a mini-stroke in the past 6 months, or a serious blood clot in a vein or lung in the past 3 months
  • You have an autoimmune disease (where the immune system attacks the body) that has required ongoing medical treatment within the past 2 years (some replacement therapies like thyroid medication or insulin are exceptions — confirm with trial site)
  • You need to take steroid tablets or injections on a long-term basis (regular use of inhalers for asthma or COPD may still be acceptable — confirm with trial site)
  • You have been diagnosed with another type of cancer in the past 5 years (some skin cancers that were fully treated may be exceptions — confirm with trial site)
  • You have a known mental health condition or substance use problem that could make it difficult to follow the trial requirements
  • You are known to have HIV, syphilis, or active tuberculosis
  • You have untreated active hepatitis B (some people with hepatitis B may still be eligible if their virus levels are very low and they are on treatment — confirm with trial site)
  • You have active hepatitis C infection confirmed by blood tests
  • You have received a live vaccine (such as a live flu nasal spray) within 30 days before starting the trial (injected inactivated flu vaccines are acceptable)
  • You have another medical condition, past treatment, or abnormal test result that the trial doctors believe could affect your safety or the trial results
  • You have a local or widespread condition unrelated to cancer that could put you at higher medical risk during the trial
  • The trial doctor does not feel that joining the trial would be in your best interest for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Registry
ClinicalTrials.gov
Start date
1 December 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Concordance Rate between PTC drug-sensitivity results and clinical response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov